Quanta Technologies

Quanta Dialysis Technologies is a medical technology company that has developed the SC+, a high-performance, portable hemodialysis system designed to provide flexible treatment options across the continuum of care. The SC+ system is engineered to deliver the power and performance of large facility-based machines in a compact, easy-to-use format, making it suitable for use in hospitals, post-acute care facilities, and at home. The company's technology utilizes a unique disposable cartridge system that simplifies the dialysis process and reduces the burden on healthcare providers and patients. Quanta aims to transform the dialysis market by improving patient access to high-quality care and enabling greater independence for those requiring renal replacement therapy. The company is headquartered in the UK with significant operations in the United States, supported by a strong investor base including Glenview Capital and Koch Disruptive Technologies.